دوره 3، شماره 2 - ( 5-1402 )
جلد 3 شماره 2 صفحات 48-29 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zandieh M, akbarein H. Economic and social consequences of the COVID-19 pandemic from a public health perspective. Zoonosis 2023; 3 (2) :29-48
URL: http://zoonosis.ir/article-1-83-fa.html
URL: http://zoonosis.ir/article-1-83-fa.html
زندیه محمد آراد، اکبرین حسام الدین. پیامد های اقتصادی و اجتماعی پاندمی کووید-19 از دیدگاه سلامت عمومی. مجله بيماری های قابل انتقال بين انسان و حيوان. 1402; 3 (2) :29-48
، akbarein@ut.ac.ir
چکیده: (563 مشاهده)
بیماری کووید-19 اواخر سال 2019 میلادی در کشور چین شروع شد و با آغاز شیوع این بیماری در شهرهای مختلف چین و کشورهای مختلف، قرنطینه‌ی سراسری و راهکارهای مداخله‌ای متعددی در جهت کنترل این پاندمی نیز آغاز گردید. در نهایت پس از حدود سه سال مبارزه با این بیماری به پایان مرحله اضطراری پاندمی کووید-19 نزدیک شده‌ایم. علاوه بر اینکه این بیماری شدیداً مسری در این سال‌ها نبض اقتصاد جهان را نابود کرد، از طرفی راهکارهای مداخله‌ای مبارزه با این بیماری نیز پیامدها و تاثیرات بزرگی بر اقتصاد و سلامت عمومی جامعه گذاشته است. بسیاری از پیامدهای اقتصادی و اجتماعی سال‌های بعد مشخص می‌گردند. در این مطالعه با جست‌وجوی کلید واژه‌ی «کووید-19» همراه با «اقتصاد» یا «پیامد اقتصادی» و «کووید-19» همراه با «اجتماعی» یا «پیامد اجتماعی» به زبان انگلیسی در پایگاه‌های داده مانندPubmed ، Google Scholar، Science Direct و به زبان فارسی در پایگاه‌های داده‌ی (SID) و (Magiran) در بازه زمانی سال‌های 2020 تا 2023 بررسی گردیدند. اضطراب، ترس، مشکلات روانی، آسیب‌های اجتماعی و از سوی دیگر فقر، کاهش سطح درآمد صدک‌های پایین جامعه، عدم دسترسی به آموزش با کیفیت از سوی دیگر از جمله مهم‌ترین پیامدهای اجتماعی و اقتصادی این پاندمی می‌باشند. این پاندمی سبب گسترش نابرابری عمومی در سطح اجتماع چه از لحاظ رفاه اجتماعی و اقتصادی و چه از لحاظ سلامت شده است. در این مقاله مهم‌ترین عوامل موثر بر آثار اقتصادی و اجتماعی کووید-19 بررسی شده است.
مرور کتاب: مروری |
موضوع مقاله:
بهداشت عمومی
دریافت: 1402/5/6 | پذیرش: 1402/6/10 | انتشار: 1403/2/17
دریافت: 1402/5/6 | پذیرش: 1402/6/10 | انتشار: 1403/2/17
فهرست منابع
1. Smith KM, Machalaba CC, Seifman R, Feferholtz Y, Karesh WB. Infectious disease and economics: The case for considering multi-sectoral impacts. One health. 2019;7:100080. [DOI:10.1016/j.onehlt.2018.100080] [PMID] []
2. Kelvin DJ, Rubino S. Fear of the novel coronavirus. The Journal of infection in developing countries. 2020;14(01):1-2. [DOI:10.3855/jidc.12496] [PMID]
3. Zandieh Mohammad Arad; Akbarein, Hesamedin. Review on The History of Contagious Respiratory Diseases: Tuberculosis, Influenza, Plague. presented at: National Conference on Natural Products Affecting Respiratory Infections; 2021; https://civilica.com/doc/1410661 [In Persian].
4. World Health Organization (WHO). Coronavirus disease (COVID-19) pandemic. https://www.who.int/europe/emergencies/situations/covid-1
5. Lau SK, Chan JF. Coronaviruses: emerging and re-emerging pathogens in humans and animals. BioMed Central; 2015. p. 1-3. [DOI:10.1186/s12985-015-0432-z] [PMID] []
6. Centers for Disease Control and Prevention (CDC). Symptoms of COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
7. Rosales-Mendoza S, Comas-García M, González-Ortega O. Biomedical innovations to combat COVID-19. Academic Press; 2021.
8. World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/
9. Mackay IM, Arden KE. MERS coronavirus: diagnostics, epidemiology and transmission. Virology journal. 2015;12(1):1-21. [DOI:10.1186/s12985-015-0439-5] [PMID] []
10. Peiris J, Lai S, Poon L, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. The lancet. 2003;361(9366):1319-1325. [DOI:10.1016/S0140-6736(03)13077-2] [PMID]
11. De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nature reviews microbiology. 2016;14(8):523-534. [DOI:10.1038/nrmicro.2016.81] [PMID] []
12. Stadler K, Masignani V, Eickmann M, et al. SARS - beginning to understand a new virus. Nature reviews microbiology. 2003/12/01 2003;1(3):209-218. doi:10.1038/nrmicro775 [DOI:10.1038/nrmicro775] [PMID] []
13. Mackay IM, Arden KE. An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus. Viruses. 2017;9(12):369. [DOI:10.3390/v9120369] [PMID] []
14. Mancera Gracia JC, Pearce DS, Masic A, Balasch M. Influenza A virus in swine: epidemiology, challenges and vaccination strategies. Frontiers in Veterinary Science. 2020;7:647. [DOI:10.3389/fvets.2020.00647] [PMID] []
15. Yu X, Saphire EO. Development and Structural Analysis of Antibody Therapeutics for Filoviruses. Pathogens. 2022;11(3):374. [DOI:10.3390/pathogens11030374] [PMID] []
16. Petrovan SO, Aldridge DC, Bartlett H, et al. Post COVID‐19: a solution scan of options for preventing future zoonotic epidemics. Biological Reviews. 2021;96(6):2694-2715. [DOI:10.1111/brv.12774] [PMID] []
17. Rahman MT, Sobur MA, Islam MS, et al. Zoonotic diseases: etiology, impact, and control. Microorganisms. 2020;8(9):1405. [DOI:10.3390/microorganisms8091405] [PMID] []
18. Lu H, Zhao Y, Zhang J, et al. Date of origin of the SARS coronavirus strains. BMC Infectious Diseases. 2004;4(1):1-6. [DOI:10.1186/1471-2334-4-3] [PMID] []
19. Chan JF-W, Kok K-H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging microbes & infections. 2020;9(1):221-236. [DOI:10.1080/22221751.2020.1719902] [PMID] []
20. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet. 2020;395(10224):565-574. [DOI:10.1016/S0140-6736(20)30251-8] [PMID]
21. Kan B, Wang M, Jing H, et al. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. Journal of virology. 2005;79(18):11892-11900. [DOI:10.1128/JVI.79.18.11892-11900.2005] [PMID] []
22. Chan PK, Chan MC. Tracing the SARS-coronavirus. Journal of thoracic disease. 2013;5(Suppl 2):S118.
23. Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Military medical research. 2020;7:1-10. [DOI:10.1186/s40779-020-00240-0] [PMID] []
24. Ray AS, Bhattacharya K. An Overview on the Zoonotic Aspects of COVID-19. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences. 2023:1-5. [DOI:10.1007/s40011-023-01445-8] [PMID] []
25. Boldog P, Tekeli T, Vizi Z, Dénes A, Bartha FA, Röst G. Risk assessment of novel coronavirus COVID-19 outbreaks outside China. Journal of clinical medicine. 2020;9(2):571. [DOI:10.3390/jcm9020571] [PMID] []
26. Burki TK. Coronavirus in China. The Lancet Respiratory Medicine. 2020;8(3):238. [DOI:10.1016/S2213-2600(20)30056-4] [PMID]
27. Ahmad T, Baig M, Hui J. Coronavirus disease 2019 (COVID-19) pandemic and economic impact. Pakistan journal of medical sciences. 2020;36(COVID19-S4):S73. [DOI:10.12669/pjms.36.COVID19-S4.2638]
28. Shih G. China is subtly stoking COVID-19 conspiracy theories that blame the US for outbreak. Washington Post, March. 2020;5
29. Rój J, Jankowiak M. Socioeconomic determinants of health and their unequal distribution in Poland. International Journal of Environmental Research and Public Health. 2021;18(20):10856. [DOI:10.3390/ijerph182010856] [PMID] []
30. Moran-Perez G. A timeline of outbreaks from 2000 to present. Daily Sundial, February. 2020;
31. Cieplak MV. Bioterrorism policy reform and implementation in the United States: The impact of the 2001 anthrax attacks. University of Birmingham; 2013.
32. Ceylan RF, Ozkan B. The economic effects of epidemics: from SARS and MERS to COVID-19. Research Journal in Advanced Humanities. 2020;1(2):21-29. [DOI:10.58256/rjah.v1i2.132]
33. Mumps outbreak in US community has high cost burden. PharmacoEconomics & Outcomes News. 2020/01/01 2020;844(1):24-24. doi:10.1007/s40274-020-6487-0 [DOI:10.1007/s40274-020-6487-0]
34. Szucs T. The socio-economic burden of influenza. Journal of Antimicrobial Chemotherapy. 1999;44(suppl_2):11-15. doi:10.1093/jac/44.suppl_2.11 [DOI:10.1093/jac/44.suppl_2.11] [PMID]
35. Jacob ST, Crozier I, Fischer WA, et al. Ebola virus disease. Nature reviews Disease primers. 2020;6(1):13. [DOI:10.1038/s41572-020-0147-3] [PMID] []
36. (CDC) CfDCaP. History of Ebola Virus Disease (EVD) Outbreaks.
37. Corps M. Chapter 4: How does Ebola affect the economy. Retrieved February. 2019;27:2020.
38. Bank TW. Summary on the Ebola Recovery Plan.
39. Akbulaev N, Mammadov I, Aliyev V. Economic impact of COVID-19. Sylwan. 2020;164(5) [DOI:10.2139/ssrn.3649813]
40. Zhou L, Chen Z. Are CGE models reliable for disaster impact analyses? Economic Systems Research. 2021;33(1):20-46. [DOI:10.1080/09535314.2020.1780566]
41. Rose A, Benavides J, Chang SE, Szczesniak P, Lim D. The regional economic impact of an earthquake: Direct and indirect effects of electricity lifeline disruptions. Journal of regional Science. 1997;37(3):437-458. [DOI:10.1111/0022-4146.00063]
42. FEMA. Hazus: FEMA's methodology for estimating potential losses from disasters. FEMA Federal Emergency Management Agency Washington, DC; 2011.
43. Geisecke J, Burns W, Barrett A, et al. Assessment of the regional economic impacts of catastrophic Events: a CGE analysis of resource loss and behavioral effects of a radiological dispersion device attack scenario. Risk Analysis. 2012;32:583-600. [DOI:10.1111/j.1539-6924.2010.01567.x] [PMID]
44. Cutter SL. The landscape of disaster resilience indicators in the USA. Natural hazards. 2016;80(2):741-758. [DOI:10.1007/s11069-015-1993-2]
45. Rose A. Benefit-cost analysis of economic resilience actions. Oxford research encyclopedia of natural hazard science. 2017. [DOI:10.1093/acrefore/9780199389407.013.69]
46. Rose A. Economic resilience to natural and man-made disasters: Multidisciplinary origins and contextual dimensions. Environmental Hazards. 2007;7(4):383-398. [DOI:10.1016/j.envhaz.2007.10.001]
47. Rose A. COVID-19 economic impacts in perspective: A comparison to recent US disasters. International Journal of Disaster Risk Reduction. 2021;60:102317. [DOI:10.1016/j.ijdrr.2021.102317] [PMID] []
48. Control CfD, Rothstein MA, Alcalde MG, et al. Quarantine and isolation: Lessons learned from SARS. University of Louisville School of Medicine, Institute for Bioethics, Health …; 2003.
49. Manuell ME, Cukor J. Mother Nature versus human nature: public compliance with evacuation and quarantine. Disasters. 2011;35(2):417-442. [DOI:10.1111/j.1467-7717.2010.01219.x] [PMID]
50. Cheng ZJ, Shan J. 2019 Novel coronavirus: where we are and what we know. Infection. 2020;48:155-163. [DOI:10.1007/s15010-020-01401-y] [PMID] []
51. Ahmad T, Haroon, Baig M, Hui J. Coronavirus Disease 2019 (COVID-19) Pandemic and Economic Impact. Pak J Med Sci. May 2020;36(Covid19-s4):S73-s78. doi:10.12669/pjms.36.COVID19-S4.2638 [DOI:10.12669/pjms.36.COVID19-S4.2638]
52. Thrusfield M. Veterinary epidemiology. John Wiley & Sons; 2018.
53. Forsythe E, Kahn LB, Lange F, Wiczer D. Labor demand in the time of COVID-19: Evidence from vacancy postings and UI claims. Journal of public economics. 2020;189:104238. [DOI:10.1016/j.jpubeco.2020.104238] [PMID] []
54. Rojas FL, Jiang X, Montenovo L, Simon KI, Weinberg BA, Wing C. Is the cure worse than the problem itself? Immediate labor market effects of COVID-19 case rates and school closures in the US. 2020. [DOI:10.3386/w27127]
55. Goldstein JR, Lee RD. Demographic perspectives on the mortality of COVID-19 and other epidemics. Proceedings of the National Academy of Sciences. 2020;117(36):22035-22041. [DOI:10.1073/pnas.2006392117] [PMID] []
56. Lin PZ, Meissner CM. A note on long-run persistence of public health outcomes in pandemics. 2020. [DOI:10.3386/w27119]
57. Hamedi Erfan; Zandieh, Mohammad Arad. The Importance of Protecting Health Information against Cyber Attacks in Covid-19 Pandemic Era. presented at: 3rd National Conference on Cyber Defense; 2022; [In Persian].
58. Ahmed J, Malik F, Arif TB, et al. Availability of personal protective equipment (PPE) among US and Pakistani doctors in COVID-19 pandemic. Cureus. 2020;12(6)
59. Suleiman A, Bsisu I, Guzu H, et al. Preparedness of frontline doctors in Jordan healthcare facilities to COVID-19 outbreak. International Journal of Environmental Research and Public Health. 2020;17(9):3181. [DOI:10.3390/ijerph17093181] [PMID] []
60. Brodeur A, Gray D, Islam A, Bhuiyan S. A literature review of the economics of COVID‐19. Journal of Economic Surveys. 2021;35(4):1007-1044. [DOI:10.1111/joes.12423] [PMID] []
61. Gupta S, Montenovo L, Nguyen T, et al. Effects of social distancing policy on labor market outcomes. Contemporary Economic Policy. 2023;41(1):166-193. [DOI:10.1111/coep.12582] [PMID] []
62. Gourinchas P-O. Flattening the pandemic and recession curves. Mitigating the COVID economic crisis: Act fast and do whatever. 2020;31(2):57-62.
63. DiGiovanni C, Conley J, Chiu D, Zaborski J. Factors influencing compliance with quarantine in Toronto during the 2003 SARS outbreak. Biosecurity and bioterrorism: biodefense strategy, practice, and science. 2004;2(4):265-272. [DOI:10.1089/bsp.2004.2.265] [PMID]
64. Yoon M-K, Kim S-Y, Ko H-S, Lee M-S. System effectiveness of detection, brief intervention and refer to treatment for the people with post-traumatic emotional distress by MERS: a case report of community-based proactive intervention in South Korea. International journal of mental health systems. 2016;10:1-5. [DOI:10.1186/s13033-016-0083-5] [PMID] []
65. Mihashi M, Otsubo Y, Yinjuan X, Nagatomi K, Hoshiko M, Ishitake T. Predictive factors of psychological disorder development during recovery following SARS outbreak. Health Psychology. 2009;28(1):91. [DOI:10.1037/a0013674] [PMID]
66. Lee S, Chan LY, Chau AM, Kwok KP, Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Social science & medicine. 2005;61(9):2038-2046. [DOI:10.1016/j.socscimed.2005.04.010] [PMID] []
67. Marjanovic Z, Greenglass ER, Coffey S. The relevance of psychosocial variables and working conditions in predicting nurses' coping strategies during the SARS crisis: an online questionnaire survey. International journal of nursing studies. 2007;44(6):991-998. [DOI:10.1016/j.ijnurstu.2006.02.012] [PMID] []
68. Braunack-Mayer A, Tooher R, Collins JE, Street JM, Marshall H. Understanding the school community's response to school closures during the H1N1 2009 influenza pandemic. BMC public health. 2013;13(1):1-15. [DOI:10.1186/1471-2458-13-344] [PMID] []
69. Bai Y, Lin C-C, Lin C-Y, Chen J-Y, Chue C-M, Chou P. Survey of stress reactions among health care workers involved with the SARS outbreak. Psychiatric services. 2004;55(9):1055-1057. [DOI:10.1176/appi.ps.55.9.1055] [PMID]
70. Sprang G, Silman M. Posttraumatic stress disorder in parents and youth after health-related disasters. Disaster medicine and public health preparedness. 2013;7(1):105-110. [DOI:10.1017/dmp.2013.22] [PMID]
71. Liu X, Kakade M, Fuller CJ, et al. Depression after exposure to stressful events: lessons learned from the severe acute respiratory syndrome epidemic. Comprehensive psychiatry. 2012;53(1):15-23. [DOI:10.1016/j.comppsych.2011.02.003] [PMID] []
72. Taylor MR, Agho KE, Stevens GJ, Raphael B. Factors influencing psychological distress during a disease epidemic: data from Australia's first outbreak of equine influenza. BMC public health. 2008;8(1):1-13. [DOI:10.1186/1471-2458-8-347] [PMID] []
73. Czeisler MÉ, Lane RI, Petrosky E, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic-United States, June 24-30, 2020. Morbidity and Mortality Weekly Report. 2020;69(32):1049. [DOI:10.15585/mmwr.mm6932a1] [PMID] []
74. Rasmussen SA, Wang J, Li X, Cao G, Wu X, Wang Z. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID. Ann Oncol. 2020;79:19-21.
75. McGowan ML, Norris AH, Bessett D. Care churn-why keeping clinic doors open isn't enough to ensure access to abortion. The New England journal of medicine. 2020;383(6):508-510. [DOI:10.1056/NEJMp2013466] [PMID]
76. Colasanti KJ, Conner DS, Smalley SB. Understanding barriers to farmers' market patronage in Michigan: perspectives from marginalized populations. Journal of Hunger & Environmental Nutrition. 2010;5(3):316-338. [DOI:10.1080/19320248.2010.504097]
77. Kaye AD, Okeagu CN, Pham AD, et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives. Best Pract Res Clin Anaesthesiol. Oct 2021;35(3):293-306. doi:10.1016/j.bpa.2020.11.009 [DOI:10.1016/j.bpa.2020.11.009] [PMID] []
78. Yasenov VI. Who can work from home? 2020; [DOI:10.31219/osf.io/89k47] []
79. Alon T, Doepke M, Olmstead-Rumsey J, Tertilt M. The impact of COVID-19 on gender equality. 2020. [DOI:10.3386/w26947]
80. Bong C-L, Brasher C, Chikumba E, McDougall R, Mellin-Olsen J, Enright A. The COVID-19 pandemic: effects on low-and middle-income countries. Anesthesia and analgesia. 2020; [DOI:10.1213/ANE.0000000000004846] [PMID] []
81. Shuchman M. Low-and middle-income countries face up to COVID-19. Nat Med. 2020;26(7):986-8. [DOI:10.1038/d41591-020-00020-2] [PMID]
82. World Health Organization (WHO). Infodemic. https://www.who.int/health-topics/infodemic#tab=tab_1
83. Almond D, Du X, Zhang S. Did COVID-19 improve air quality near Hubei? National Bureau of Economic Research Cambridge, MA, USA; 2020.
84. Cicala S, Holland SP, Mansur ET, Muller NZ, Yates AJ. Expected health effects of reduced air pollution from COVID-19 social distancing. Atmosphere. 2021;12(8):951. [DOI:10.3390/atmos12080951]
85. Ahmed SAS, Ajisola M, Azeem K, et al. Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements. BMJ global health. 2020;5(8):e003042. [DOI:10.1136/bmjgh-2020-003042] [PMID] []
86. Mahmood S, Hasan K, Carras MC, Labrique A. Global preparedness against COVID-19: we must leverage the power of digital health. JMIR Public Health and Surveillance. 2020;6(2):e18980. [DOI:10.2196/18980] [PMID] []
87. Health TLP. COVID-19 pandemic: what's next for public health? The Lancet Public Health. 2022;7(5):e391. [DOI:10.1016/S2468-2667(22)00095-0] [PMID]
88. Zandieh, Mohammad Arad; Rajabi, Romina; Akbarein, Hesamedin. Review on Telemedicine in Animal Health. presented at: The first international telemedicine conference; 2021; https://civilica.com/doc/1563032; [In Persian].
ارسال پیام به نویسنده مسئول
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
اخلاق نشر
این نشریه با احترام به قوانین اخلاق در نشریات تابع قوانین کمیتۀ اخلاق در انتشار (COPE) می باشد و از آیین نامه اجرایی قانون پیشگیری و مقابله با تقلب در آثار علمی پیروی می نماید.
